Text Size
175 studies found for:    Leiomyoma: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Terminated Three Cycle Extension Study Evaluating Safety and Efficacy of a 25 mg Daily Dose of Proellex® In Pre-Menopausal Women With Leiomyomata Who Have Previously Completed ZPU 003 Ext
Condition: Uterine Fibroids
Intervention: Drug: Proellex®
22 Terminated Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Conditions: Uterine Fibroids;   Anemia
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Placebo
23 Recruiting Fibroid Ablation Study - Large Fibroids
Conditions: Leiomyoma;   Uterine Fibroids;   Menorrhagia
Intervention: Device: VizAblate System
24 Completed Study of Asoprisnil in the Treatment of Uterine Fibroids.
Conditions: Fibroid Uterus;   Leiomyoma;   Menorrhagia;   Metrorrhagia;   Uterine Fibroids
Intervention: Drug: Asoprisnil
25 Completed
Has Results 		A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
Conditions: Leiomyoma;   Uterine Fibroids;   Uterine Neoplasms;   Menorrhagia;   Leiomyomatosis
Interventions: Procedure: Uterine Fibroid Embolization (UFE);   Device: Contour SE™ Microspheres;   Device: Embosphere® Microspheres
26 Completed A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Condition: Leiomyoma
Interventions: Drug: Asoprisnil;   Drug: Placebo
27 Completed Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
Conditions: Leiomyoma;   Menorrhagia;   Metrorrhagia
Intervention: Drug: Asoprisnil
28 Completed A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
Conditions: Fibroid Uterus;   Leiomyoma;   Menorrhagia;   Metrorrhagia;   Uterine Fibroids
Interventions: Drug: Asoprisnil;   Drug: Placebo
29 Completed A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy
Conditions: Uterine Fibroids;   Leiomyoma
Interventions: Drug: Asoprisnil;   Drug: Placebo
30 Terminated A Study Evaluating the Safety of 25 and 50 mg Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Drug: Proellex
31 Terminated Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids
Conditions: Uterine Fibroids;   Bleeding;   Pelvic Pain
Interventions: Device: Exablate 2100;   Procedure: Myomectomy
32 Completed A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Conditions: Leiomyoma;   Menorrhagia;   Metrorrhagia
Interventions: Drug: Asoprisnil;   Drug: Placebo
33 Terminated ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
Condition: Uterine Fibroids, With Unexplained Infertility
Interventions: Device: ExAblate 2000;   Procedure: Myomectomy
34 Completed Mifepristone for Treatment of Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Drug: Mifepristone
35 Completed MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
Conditions: Uterine Leiomyoma;   Uterine Fibroids
Intervention: Device: ExAblate 2000
36 Completed A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
Condition: Uterine Fibroids
Interventions: Drug: Leuprorelin (GF);   Drug: Leuprorelin (GC)
37 Recruiting Fibroid Ablation Study
Conditions: Leiomyoma;   Uterine Fibroids;   Menorrhagia
Intervention: Device: VizAblate System
38 Recruiting ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids
Condition: Uterine Fibroid(s)
Intervention: Device: ExAblate UF V2
39 Unknown † Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Drug: Mifepristone
40 Active, not recruiting PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
Condition: Uterine Fibroids.
Interventions: Drug: PGL4001 5 mg;   Drug: PGL4001 10 mg
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years